Form 4 for KRYS Krystal Biotech, Inc.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-03-01 · accession 0001711279-23-000012 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-03-01 | KRYS | ROSSI DINO A | Dir | S - Sale | $83.25 | -40.0K | 83.7K | -32% | -$3.33M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-01 | S | D | 40,000 | $83.25 | 83,691 | D | — | — | (F1) The transaction was executed in multiple trades ranging from $82.245 to $83.67. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |